TY - STD TI - Canadian cancer statistics 2008. [http://www.cancer.ca/canadawide/about%20cancer/cancer%20statistics/~/media/CCS/Canada%20wide/Files%20List/English%20files%20heading/pdf%20not%20in%20publications%20section/Canadian%20Cancer%20Society%20Statistics%20PDF%202008_614137951.ashx] UR - http://www.cancer.ca/canadawide/about%20cancer/cancer%20statistics/~/media/CCS/Canada%20wide/Files%20List/English%20files%20heading/pdf%20not%20in%20publications%20section/Canadian%20Cancer%20Society%20Statistics%20PDF%202008_614137951.ashx ID - ref1 ER - TY - BOOK PY - 1998 DA - 1998// TI - Programmatic Guidelines for Screening for Cancer of the Cervix in Canada ID - ref2 ER - TY - STD TI - Cervical Cancer Screening in Canada: 1998 Surveillance Report. [http://www.phac-aspc.gc.ca/publicat/ccsic-dccuac/index-eng.php] UR - http://www.phac-aspc.gc.ca/publicat/ccsic-dccuac/index-eng.php ID - ref3 ER - TY - JOUR AU - Dobson, S. AU - Deeks, S. M. D. PY - 2007 DA - 2007// TI - An Advisory Committee Statement (ACS), National Advisory Committee on Immuzation (NACI): Statement on human papillomavirus vaccine JO - Canada Communicable Disease Report - Relevé des maladies transmissibles au Canada (CCDR-RMTC) VL - 33 ID - Dobson2007 ER - TY - JOUR AU - Bosch, F. X. AU - Manos, M. M. AU - Munoz, N. AU - Sherman, M. AU - Jansen, A. M. AU - Peto, J. AU - Schiffman, M. H. AU - Moreno, V. AU - Kurman, R. AU - Shah, K. V. PY - 1995 DA - 1995// TI - Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group JO - J Natl Cancer Inst VL - 87 UR - https://doi.org/10.1093/jnci/87.11.796 DO - 10.1093/jnci/87.11.796 ID - Bosch1995 ER - TY - JOUR AU - Munoz, N. AU - Bosch, F. X. AU - Castellsague, X. AU - Diaz, M. AU - de, S. S. AU - Hammouda, D. AU - Shah, K. V. AU - Meijer, C. J. PY - 2004 DA - 2004// TI - Against which human papillomavirus types shall we vaccinate and screen? The international perspective JO - Int J Cancer VL - 111 UR - https://doi.org/10.1002/ijc.20244 DO - 10.1002/ijc.20244 ID - Munoz2004 ER - TY - JOUR AU - Brisson, M. AU - Van, d. V. AU - De, W. P. AU - Boily, M. C. PY - 2007 DA - 2007// TI - The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada JO - Vaccine VL - 25 UR - https://doi.org/10.1016/j.vaccine.2007.04.086 DO - 10.1016/j.vaccine.2007.04.086 ID - Brisson2007 ER - TY - JOUR AU - Paavonen, J. AU - Naud, P. AU - Salmeron, J. AU - Wheeler, C. AU - Chow, S. N. AU - Apter, D. L. AU - Kitchener, H. C. PY - 2009 DA - 2009// TI - Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)61248-4 DO - 10.1016/S0140-6736(09)61248-4 ID - Paavonen2009 ER - TY - JOUR AU - Paavonen, J. AU - Jenkins, D. AU - Bosch, F. X. AU - Naud, P. AU - Salmeron, J. AU - Wheeler, C. M. AU - Chow, S. N. AU - Apter, D. L. AU - Kitchener, H. C. AU - Castellsague, X. PY - 2007 DA - 2007// TI - Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial JO - Lancet VL - 369 UR - https://doi.org/10.1016/S0140-6736(07)60946-5 DO - 10.1016/S0140-6736(07)60946-5 ID - Paavonen2007 ER - TY - JOUR AU - Harper, D. M. AU - Franco, E. L. AU - Wheeler, C. M. AU - Moscicki, A. B. AU - Romanowski, B. AU - Roteli-Martins, C. M. AU - Jenkins, D. AU - Schuind, A. AU - Costa Clemens, S. A. AU - Dubin, G. PY - 2006 DA - 2006// TI - Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial JO - Lancet VL - 367 UR - https://doi.org/10.1016/S0140-6736(06)68439-0 DO - 10.1016/S0140-6736(06)68439-0 ID - Harper2006 ER - TY - JOUR AU - Harper, D. M. AU - Franco, E. L. AU - Wheeler, C. AU - Ferris, D. G. AU - Jenkins, D. AU - Schuind, A. AU - Zahaf, T. AU - Innis, B. AU - Naud, P. AU - De Carvalho, N. S. PY - 2004 DA - 2004// TI - Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial JO - Lancet VL - 364 UR - https://doi.org/10.1016/S0140-6736(04)17398-4 DO - 10.1016/S0140-6736(04)17398-4 ID - Harper2004 ER - TY - JOUR AU - Villa, L. L. AU - Costa, R. L. AU - Petta, C. A. AU - Andrade, R. P. AU - Ault, K. A. AU - Giuliano, A. R. AU - Wheeler, C. M. AU - Koutsky, L. A. AU - Malm, C. AU - Lehtinen, M. PY - 2005 DA - 2005// TI - Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial JO - Lancet Oncol VL - 6 UR - https://doi.org/10.1016/S1470-2045(05)70101-7 DO - 10.1016/S1470-2045(05)70101-7 ID - Villa2005 ER - TY - JOUR AU - Koutsky, L. A. AU - Ault, K. A. AU - Wheeler, C. M. AU - Brown, D. R. AU - Barr, E. AU - Alvarez, F. B. AU - Chiacchierini, L. M. AU - Jansen, K. U. PY - 2002 DA - 2002// TI - A controlled trial of a human papillomavirus type 16 vaccine JO - N Engl J Med VL - 347 UR - https://doi.org/10.1056/NEJMoa020586 DO - 10.1056/NEJMoa020586 ID - Koutsky2002 ER - TY - JOUR AU - Carter, J. J. AU - Koutsky, L. A. AU - Wipf, G. C. AU - Christensen, N. D. AU - Lee, S. K. AU - Kuypers, J. AU - Kiviat, N. AU - Galloway, D. A. PY - 1996 DA - 1996// TI - The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women JO - J Infect Dis VL - 174 UR - https://doi.org/10.1093/infdis/174.5.927 DO - 10.1093/infdis/174.5.927 ID - Carter1996 ER - TY - JOUR AU - Stanley, M. PY - 2006 DA - 2006// TI - Immune responses to human papillomavirus JO - Vaccine VL - 24 UR - https://doi.org/10.1016/j.vaccine.2005.09.002 DO - 10.1016/j.vaccine.2005.09.002 ID - Stanley2006 ER - TY - JOUR AU - Unckell, F. AU - Streeck, R. E. AU - Sapp, M. PY - 1997 DA - 1997// TI - Generation and neutralization of pseudovirions of human papillomavirus type 33 JO - J Virol VL - 71 ID - Unckell1997 ER - TY - JOUR AU - Wang, Z. AU - Christensen, N. AU - Schiller, J. T. AU - Dillner, J. PY - 1997 DA - 1997// TI - A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera JO - J Gen Virol VL - 78 UR - https://doi.org/10.1099/0022-1317-78-9-2209 DO - 10.1099/0022-1317-78-9-2209 ID - Wang1997 ER - TY - JOUR AU - Christensen, N. D. AU - Kirnbauer, R. AU - Schiller, J. T. AU - Ghim, S. J. AU - Schlegel, R. AU - Jenson, A. B. AU - Kreider, J. W. PY - 1994 DA - 1994// TI - Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes JO - Virology VL - 205 UR - https://doi.org/10.1006/viro.1994.1649 DO - 10.1006/viro.1994.1649 ID - Christensen1994 ER - TY - JOUR AU - Brisson, M. AU - Edmunds, W. J. PY - 2003 DA - 2003// TI - Economic evaluation of vaccination programs: the impact of herd-immunity JO - Med Decis Making VL - 23 UR - https://doi.org/10.1177/0272989X02239651 DO - 10.1177/0272989X02239651 ID - Brisson2003 ER - TY - JOUR AU - Garnett, G. P. PY - 2005 DA - 2005// TI - Role of herd immunity in determining the effect of vaccines against sexually transmitted disease JO - J Infect Dis VL - 191 UR - https://doi.org/10.1086/425271 DO - 10.1086/425271 ID - Garnett2005 ER - TY - STD TI - The cost-effectiveness of HPV vaccination in the United States. [http://www.cdc.gov/EID/content/14/2/pdfs/244.pdf] UR - http://www.cdc.gov/EID/content/14/2/pdfs/244.pdf ID - ref21 ER - TY - JOUR AU - Elbasha, E. H. AU - Dasbach, E. J. AU - Insinga, R. P. PY - 2007 DA - 2007// TI - Model for assessing human papillomavirus vaccination strategies JO - Emerg Infect Dis VL - 13 UR - https://doi.org/10.3201/eid1301.060438 DO - 10.3201/eid1301.060438 ID - Elbasha2007 ER - TY - JOUR AU - Insinga, R. P. AU - Dasbach, E. J. AU - Elbasha, E. H. AU - Puig, A. AU - Reynales-Shigematsu, L. M. PY - 2007 DA - 2007// TI - Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: a transmission dynamic model-based evaluation JO - Vaccine VL - 26 UR - https://doi.org/10.1016/j.vaccine.2007.10.056 DO - 10.1016/j.vaccine.2007.10.056 ID - Insinga2007 ER - TY - JOUR AU - Taira, A. V. AU - Neukermans, C. P. AU - Sanders, G. D. PY - 2004 DA - 2004// TI - Evaluating human papillomavirus vaccination programs JO - Emerg Infect Dis VL - 10 UR - https://doi.org/10.3201/eid1011.040222 DO - 10.3201/eid1011.040222 ID - Taira2004 ER - TY - JOUR AU - Kulasingam, S. AU - Connelly, L. AU - Conway, E. AU - Hocking, J. S. AU - Myers, E. AU - Regan, D. G. AU - Roder, D. AU - Ross, J. AU - Wain, G. PY - 2007 DA - 2007// TI - A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program JO - Sex Health VL - 4 UR - https://doi.org/10.1071/SH07043 DO - 10.1071/SH07043 ID - Kulasingam2007 ER - TY - JOUR AU - Bauch, C. T. AU - Anonychuk, A. M. AU - Pham, B. Z. AU - Gilca, V. AU - Duval, B. AU - Krahn, M. D. PY - 2007 DA - 2007// TI - Cost-utility of universal hepatitis A vaccination in Canada JO - Vaccine VL - 25 UR - https://doi.org/10.1016/j.vaccine.2007.10.001 DO - 10.1016/j.vaccine.2007.10.001 ID - Bauch2007 ER - TY - JOUR AU - Bergeron, C. AU - Largeron, N. AU - McAllister, R. AU - Mathevet, P. AU - Remy, V. PY - 2008 DA - 2008// TI - Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France JO - Int J Technol Assess Health Care VL - 24 UR - https://doi.org/10.1017/S0266462307080026 DO - 10.1017/S0266462307080026 ID - Bergeron2008 ER - TY - JOUR AU - Boot, H. J. AU - Wallenburg, I. AU - de Melker, H. E. AU - Mangen, M. J. AU - Gerritsen, A. A. AU - Maas, N. A. v. a. n. d. e. r. AU - Berkhof, J. AU - Meijer, C. J. AU - Kimman, T. G. PY - 2007 DA - 2007// TI - Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands JO - Vaccine VL - 25 UR - https://doi.org/10.1016/j.vaccine.2007.05.061 DO - 10.1016/j.vaccine.2007.05.061 ID - Boot2007 ER - TY - JOUR AU - Chesson, H. W. AU - Ekwueme, D. U. AU - Saraiya, M. AU - Markowitz, L. E. PY - 2008 DA - 2008// TI - Cost-effectiveness of human papillomavirus vaccination in the United States JO - Emerg Infect Dis VL - 14 UR - https://doi.org/10.3201/eid1402.070499 DO - 10.3201/eid1402.070499 ID - Chesson2008 ER - TY - JOUR AU - Garnett, G. P. AU - Kim, J. J. AU - French, K. AU - Goldie, S. J. PY - 2006 DA - 2006// TI - Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes JO - Vaccine VL - 24 Suppl 3 ID - Garnett2006 ER - TY - JOUR AU - Ginsberg, G. M. AU - Fisher, M. AU - Ben-Shahar, I. AU - Bornstein, J. PY - 2007 DA - 2007// TI - Cost-utility analysis of vaccination against HPV in Israel JO - Vaccine VL - 25 UR - https://doi.org/10.1016/j.vaccine.2007.07.018 DO - 10.1016/j.vaccine.2007.07.018 ID - Ginsberg2007 ER - TY - JOUR AU - Goldie, S. J. AU - Kohli, M. AU - Grima, D. AU - Weinstein, M. C. AU - Wright, T. C. AU - Bosch, F. X. AU - Franco, E. PY - 2004 DA - 2004// TI - Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine JO - J Natl Cancer Inst VL - 96 UR - https://doi.org/10.1093/jnci/djh104 DO - 10.1093/jnci/djh104 ID - Goldie2004 ER - TY - JOUR AU - Goldie, S. J. AU - Kim, J. J. AU - Kobus, K. AU - Goldhaber-Fiebert, J. D. AU - Salomon, J. AU - O'shea, M. K. AU - Xavier, B. F. AU - de, S. S. AU - Franco, E. L. PY - 2007 DA - 2007// TI - Cost-effectiveness of HPV 16, 18 vaccination in Brazil JO - Vaccine VL - 25 UR - https://doi.org/10.1016/j.vaccine.2007.05.058 DO - 10.1016/j.vaccine.2007.05.058 ID - Goldie2007 ER - TY - JOUR AU - Sanders, G. D. AU - Taira, A. V. PY - 2003 DA - 2003// TI - Cost-effectiveness of a potential vaccine for human papillomavirus JO - Emerg Infect Dis VL - 9 UR - https://doi.org/10.3201/eid0901.020168 DO - 10.3201/eid0901.020168 ID - Sanders2003 ER - TY - JOUR AU - Kim, J. J. AU - ndres-Beck, B. AU - Goldie, S. J. PY - 2007 DA - 2007// TI - The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting JO - Br J Cancer VL - 97 UR - https://doi.org/10.1038/sj.bjc.6604023 DO - 10.1038/sj.bjc.6604023 ID - Kim2007 ER - TY - JOUR AU - Kulasingam, S. L. AU - Benard, S. AU - Barnabas, R. V. AU - Largeron, N. AU - Myers, E. R. PY - 2008 DA - 2008// TI - Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis JO - Cost Eff Resour Alloc VL - 6 UR - https://doi.org/10.1186/1478-7547-6-4 DO - 10.1186/1478-7547-6-4 ID - Kulasingam2008 ER - TY - JOUR AU - Debicki, D. AU - Ferko, N. AU - Demarteau, N. AU - Gallivan, S. AU - Bauch, C. AU - Anonychuk, A. AU - Mantovani, L. AU - Capri, S. AU - Chou, C. Y. AU - Standaert, B. PY - 2008 DA - 2008// TI - Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccination JO - Vaccine VL - 26 UR - https://doi.org/10.1016/j.vaccine.2008.02.040 DO - 10.1016/j.vaccine.2008.02.040 ID - Debicki2008 ER - TY - JOUR AU - Kohli, M. AU - Ferko, N. AU - Martin, A. AU - Franco, E. L. AU - Jenkins, D. AU - Gallivan, S. AU - Sherlaw-Johnson, C. AU - Drummond, M. PY - 2007 DA - 2007// TI - Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK JO - Br J Cancer VL - 96 UR - https://doi.org/10.1038/sj.bjc.6603501 DO - 10.1038/sj.bjc.6603501 ID - Kohli2007 ER - TY - CHAP PY - 2000 DA - 2000// TI - Pap smear, by age group, women aged 18 to 69 years, Canada, provinces, territories, health regions (January 2000 boundaries) and peer groups, every 2 years BT - Canadian Community Health Survey: ID - ref39 ER - TY - CHAP AU - Mitchell, M. F. AU - Tortolero-Luna, G. AU - Wright, T. AU - Sarkar, A. AU - Richards-Kortum, R. AU - Hong, W. K. AU - Schottenfeld, D. PY - 1996 DA - 1996// TI - Cervical human papillomavirus infection and intraepithelial neoplasia: a review BT - J Natl Cancer Inst Monogr ID - Mitchell1996 ER - TY - STD TI - Canadian Cancer Registry, Public Health Agency of Canada, 1990-2001. 2009 ID - ref41 ER - TY - CHAP AU - De Carvalho, N. S. AU - Roteli-Martins, C. M. AU - Teixeira, J. AU - Naud, P. AU - de Borba, P. AU - Zahaf, T. AU - Sanchez, N. AU - Schuind, A. PY - 2009 DA - 2009// TI - Immunogenicity and safety of HPV-16/18 AS04-Adjuvanted vaccine up to 7.3Y BT - 25th International papillomavirus conference; 8 ID - De Carvalho2009 ER - TY - STD TI - David MP, Van HK, Hardt K, Tibaldi F, Dubin G, Descamps D, Van DP: Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses. Gynecol Oncol. ID - ref43 ER - TY - JOUR AU - Hethcote, H. W. AU - Lewis, M. A. AU - van den Driessche, P. PY - 1989 DA - 1989// TI - An epidemiological model with a delay and a nonlinear incidence rate JO - J Math Biol VL - 27 UR - https://doi.org/10.1007/BF00276080 DO - 10.1007/BF00276080 ID - Hethcote1989 ER - TY - JOUR AU - Barnabas, R. V. AU - Laukkanen, P. AU - Koskela, P. AU - Kontula, O. AU - Lehtinen, M. AU - Garnett, G. P. PY - 2006 DA - 2006// TI - Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses JO - PLoS Med VL - 3 UR - https://doi.org/10.1371/journal.pmed.0030138 DO - 10.1371/journal.pmed.0030138 ID - Barnabas2006 ER - TY - BOOK AU - Anderson, R. M. AU - May, R. M. AU - Anderson, B. PY - 1992 DA - 1992// TI - Infectious diseases of humans: dynamics and control PB - Oxford University Press CY - New York, USA ID - Anderson1992 ER - TY - CHAP AU - Bauch, C. T. AU - Anonychuk, A. M. AU - Effelterre, T. V. AU - Pham, B. Z. AU - Merid, M. F. PY - 2009 DA - 2009// TI - Incorporating Herd Immunity Effects into Cohort Models of Vaccine Cost-Effectiveness BT - Med Decis Making ID - Bauch2009 ER - TY - BOOK AU - Krahn, M. AU - McLachlin, M. AU - Pham, B. AU - Rosen, B. AU - Sander, B. AU - Grootendorst, P. AU - Tomlinson, G. AU - John-Baptiste, A. AU - Frikemerid, M. AU - Hong Chen, M. PY - 2008 DA - 2008// TI - Liquid-based techniques for cervical cancer screening: a systematic review and cost-effectiveness analysis. Ottawa ID - Krahn2008 ER - TY - STD TI - Prices and prices indexes: Consumer price indexes. [http://www.statcan.gc.ca] UR - http://www.statcan.gc.ca ID - ref49 ER - TY - CHAP AU - Colucci, R. AU - Hryniuk, W. AU - Savage, C. PY - 2008 DA - 2008// TI - HPV vaccination programs in Canada: Are we hitting the mark? BT - Report Card on Cancer in Canada ID - Colucci2008 ER - TY - STD TI - GDP per capita. [http://tableaudebordmontreal.com/indicateurs/activiteeconomique/pibpercapita.en.html] UR - http://tableaudebordmontreal.com/indicateurs/activiteeconomique/pibpercapita.en.html ID - ref51 ER - TY - JOUR AU - Sauvageau, C. AU - Duval, B. AU - Gilca, V. AU - Lavoie, F. AU - Ouakki, M. PY - 2007 DA - 2007// TI - Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada JO - BMC Public Health VL - 7 UR - https://doi.org/10.1186/1471-2458-7-304 DO - 10.1186/1471-2458-7-304 ID - Sauvageau2007 ER - TY - STD TI - Is it cost-effective to vaccinate girls and boys with the HPV vaccine?. [http://www.cdc.ubc.ca/Publications/Presentations/FM_HPV_May%202007.pdf] UR - http://www.cdc.ubc.ca/Publications/Presentations/FM_HPV_May%202007.pdf ID - ref53 ER - TY - JOUR AU - Beutels, P. AU - Edmunds, W. J. AU - Antonanzas, F. AU - De Wit, G. A. AU - Evans, D. AU - Feilden, R. AU - Fendrick, A. M. AU - Ginsberg, G. M. AU - Glick, H. A. AU - Mast, E. PY - 2002 DA - 2002// TI - Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis JO - Pharmacoeconomics VL - 20 UR - https://doi.org/10.2165/00019053-200220010-00001 DO - 10.2165/00019053-200220010-00001 ID - Beutels2002 ER - TY - JOUR AU - Bos, J. M. AU - Beutels, P. AU - Annemans, L. AU - Postma, M. J. PY - 2004 DA - 2004// TI - Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases JO - Pharmacoeconomics VL - 22 UR - https://doi.org/10.2165/00019053-200422180-00002 DO - 10.2165/00019053-200422180-00002 ID - Bos2004 ER - TY - JOUR AU - Crott, R. PY - 2007 DA - 2007// TI - Economic analysis of HPV-vaccines: not so simple? JO - Vaccine VL - 25 UR - https://doi.org/10.1016/j.vaccine.2007.09.003 DO - 10.1016/j.vaccine.2007.09.003 ID - Crott2007 ER - TY - JOUR AU - Mayrand, M. H. AU - Duarte-Franco, E. AU - Rodrigues, I. AU - Walter, S. D. AU - Hanley, J. AU - Ferenczy, A. AU - Ratnam, S. AU - Coutlee, F. AU - Franco, E. L. PY - 2007 DA - 2007// TI - Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa071430 DO - 10.1056/NEJMoa071430 ID - Mayrand2007 ER - TY - JOUR AU - Mittmann, N. AU - Trakas, K. AU - Risebrough, N. AU - Liu, B. A. PY - 1999 DA - 1999// TI - Utility scores for chronic conditions in a community-dwelling population JO - Pharmacoeconomics VL - 15 UR - https://doi.org/10.2165/00019053-199915040-00004 DO - 10.2165/00019053-199915040-00004 ID - Mittmann1999 ER - TY - STD TI - Health Outcomes Data Repository. [https://www.crc-limited.co.uk] UR - https://www.crc-limited.co.uk ID - ref59 ER - TY - CHAP AU - Insinga, R. PY - 2005 DA - 2005// TI - Health State transitions following an abnormal pap smear: implications for health utility assessment in cost-effectiveness analyses BT - 22nd International Papillomavirus Conference and Clinical Workshop ID - Insinga2005 ER - TY - STD TI - Appendix 11: Human Papillomavirus. Vaccines for the 21st century: a tool for decisionmaking. Edited by: Stratton KR, Durch JS, Lawrence S. 2000, Washington D.C.: National Academy Press, 213-221. ID - ref61 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/9/401/prepub UR - http://www.biomedcentral.com/1471-2458/9/401/prepub ID - ref62 ER -